Company Updates

Announcements

MiraVista Diagnostics has been an industry leader in fungal infection diagnostics since 2002. Our researchers and clinical laboratory scientists continue to make significant contributions by publishing their research findings, introducing new diagnostic tests and presenting at industry conferences. Check back for the latest fungal infection announcements & fungal infection alerts.

News + Events

ALERT: Thanksgiving Holiday Schedule: Lab & Office CLOSED Thursday, November 22

MiraVista Diagnostics’ office and laboratory will be CLOSED for Thanksgiving on Thursday, November 22, 2018. Please keep our holiday schedule in mind when you are shipping specimens or requesting diagnostic test results. We will re-open Friday, November 23 and operate…
READ MORE →

MiraVista to Receive Economic Incentives from IEDC for Expansion Efforts

Indiana Economic Development Corporation Offers economic incentives to MiraVista Diagnostics. This includes $275,000 in tax credits and $50,000 in training grants to hire additional employees and expand its corporate headquarters and diagnostic laboratory in Indianapolis.

MiraVista Diagnostics is Participating in 2018 ID Week in San Francisco

MiraVista Diagnostics is participating in 2018 ID Week in San Francisco on October 3-7, 2018. Visit us at booth #1032. Representatives from MiraVista will be available to discuss our latest mycology research and menu of diagnostic tests for serious fungal…
READ MORE →

MiraVista is a Sponsor & Poster Presenter @ 2018 MSGERC Biennial Meeting in Big Sky, Montana

MiraVista Diagnostics is a sponsor and poster presenter at the 2018 Biennial Meeting of the Mycoses Study Group Education and Research Consortium (MSGERC) in Big Sky, Montana on September 25-28, 2018. Poster: Largest Study of Histoplasma Meningitis Debunks Assumptions of…
READ MORE →

MiraVista Diagnostics Supports 2018 Fungal Disease Awareness Week

August 13-17 is 2018 Fungal Disease Awareness Week. CDC and partners have organized this week to highlight the importance of recognizing serious fungal diseases early enough in the course of a patient’s illness to provide life-saving treatment. MiraVista Diagnostics supports…
READ MORE →

Visit MiraVista at ASM Microbe 2018 in Atlanta

MiraVista Diagnostics is exhibiting at ASM Microbe 2018 in Atlanta on June 7-11, 2018. Please stop by our booth to talk with one of our team members about diagnostic options for serious fungal infections. For more information about ASM Microbe…
READ MORE →

Celebrate 2018 Medical Laboratory Professionals Week With MiraVista

April 22-28 is 2018 Medical Laboratory Professionals Week, which is celebrated each year to increase public understanding of and appreciation for laboratory personnel. The theme for this important industry campaign has been “Laboratory Professionals Get Results” since 2010. MiraVista Celebrates 2018…
READ MORE →

MiraVista Receives $630,000 in Federal & State Research Grants

National Institutes of Health (NIH) and the State of Indiana Awarded MiraVista Diagnostics More Than $630,000 in Grant Funding to Support Fungal Disease Research to Develop a New Rapid Detection Test for Coccidioidomycosis MiraVista Diagnostics, LLC (MiraVista), a developer of…
READ MORE →

MiraVista is Participating in the 62nd Annual Cocci Study Group Meeting in Flagstaff, Arizona

MiraVista Diagnostics is participating in the 62nd Annual Cocci Study Group Meeting on April 13-14 in Flagstaff, Arizona. Representatives from the company will be available to discuss MiraVista’s menu of diagnostic tests for serious fungal infections. To learn more about…
READ MORE →

Inside Indiana Business Life Sciences Features MiraVista Diagnostics

Inside Indiana Business recently featured Indianapolis headquartered MiraVista Diagnostics in its Life Sciences Indiana publication. During the interview, Dr. Lawrence Joseph Wheat shared exciting news about the company’s research initiatives and expansion plans. Read the article below or link directly to…
READ MORE →

MiraVista is Attending the 2018 SCACM Spring Meeting in French Lick, Indiana

MiraVista Diagnostics is attending the South Central Association for Clinical Microbiology’s 2018 SCACM Spring Meeting in French Lick, Indiana on March 7-10, 2018. Representatives from the company’s clinical laboratory will be available to discuss MiraVista’s menu of diagnostic tests for…
READ MORE →

NIH Approved Institutional Biosafety Committee (IBC) First Meeting Scheduled for January 29

In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA complies with NIH guidelines….
READ MORE →

MiraVista Diagnostics is Participating in 2017 ID Week in San Diego

MiraVista Diagnostics is participating in 2017 ID Week in San Diego on October 4-8, 2017. Representatives from the company’s clinical laboratory team will be available to discuss our latest mycology research and menu of diagnostic tests for serious fungal infections….
READ MORE →

MiraVista Diagnostics Supports Fungal Disease Awareness Week

August 14–18, 2017, is the first Fungal Disease Awareness Week. CDC and partners have organized this week to highlight the importance of recognizing serious fungal diseases early enough in the course of a patient’s illness to provide life-saving treatment. MiraVista…
READ MORE →

MiraVista is Participating in the 2017 Coccidioidomycosis Study Group Symposium

MiraVista Diagnostics is participating in the 2017 Coccidioidomycosis Study Group Symposium on August 11-13 at the Stanford University Medical School. Representatives from the company’s clinical laboratory will be available to discuss MiraVista’s menu of diagnostic tests for serious fungal infections….
READ MORE →

Visit MiraVista Diagnostics at ASM Microbe 2017 in New Orleans

MiraVista Diagnostics is exhibiting at ASM Microbe 2017 in New Orleans on June 1-5. Please stop by our booth to talk with one of our team members about diagnostic options for serious fungal infections. For more information about ASM Microbe…
READ MORE →

MiraVista is Participating in the 2017 Canadian Association for Clinical Microbiology & Infectious Diseases Annual Conference in Toronto

MiraVista Diagnostics is participating in the 2017 Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference in Toronto on May 3-6, 2017. Representatives from the company’s clinical laboratory will be available to discuss MiraVista’s menu of diagnostic tests for…
READ MORE →

Celebrate 2017 Medical Laboratory Professionals Week With MiraVista

April 23-29, 2017 is Medical Laboratory Professionals Week, which is celebrated the last full week of April each year to increase public understanding of and appreciation for laboratory personnel. The theme for this important industry campaign has been “Laboratory Professionals Get Results”…
READ MORE →

MiraVista Diagnostics is Attending the 2017 SCACM Spring Meeting in Indianapolis

MiraVista Diagnostics is attending the South Central Association for Clinical Microbiology’s 2017 SCACM Spring Meeting in Indianapolis on March 22 – 25, 2017. Representatives from the company’s clinical laboratory will be available to discuss MiraVista’s menu of diagnostic tests for…
READ MORE →

MiraVista is Attending the 2nd Annual Mayo Clinic Update on ID for Primary Care in Phoenix, AZ

MiraVista Diagnostics is attending the 2nd Annual Mayo Clinic Update on Infectious Diseases for Primary Care at the Mayo Clinic Hospital – Jaunita Kious Waugh Auditorium in Phoenix, Arizona on January 21-22, 2017. This continuing education course offers primary care…
READ MORE →

NEW: MVista® Histoplasma Antibody IgG IgM EIA

Improve Diagnosis of Acute Pulmonary Histoplasmosis by Combining Antigen & Antibody Testing Review the technical specifications for the NEW MVista® Histoplasma Antibody IgG IgM EIA>> CLINICAL BACKGROUND Acute pulmonary histoplasmosis (APH) can be severe, especially following heavy exposure and is…
READ MORE →

BULLETIN: CSTE Revised Its Histoplasmosis Position Statement at the 2016 Annual Conference

The Council of State and Territorial Epidemiologists (CSTE) approved the Infectious Disease Committee’s revisions to the histoplasmosis position statement, “Standardized Surveillance Case Definition for Histoplasmosis” at the organization’s annual conference in Anchorage, Alaska on June 19-23, 2016. Review the revised…
READ MORE →

FEATURE: Diagnosing Histoplasmosis by Antigen Detection

FEATURED CASE REPORT FROM THE DESK OF: Lawrence Joseph Wheat, MD Medical Director, Founder & President of MiraVista Diagnostics Here is an important patient case report I’d like to share with colleagues about diagnosing histoplasmosis by antigen detection. I welcome…
READ MORE →

NEW: MVista® Coccidioides Antibody IgG IgM EIA

Improve Coccidioidomycosis Diagnosis with a New, More Sensitive, Anti-Coccidioides Antibody Enzyme Immunoassay CLINICAL BACKGROUND Coccidioidomycosis is endemic to the southwestern United States, northern Mexico and regions of Central and South America. Coccidioidomycosis often presents as community acquired pneumonia (CAP) and…
READ MORE →

MiraVista Diagnostics is Adding Jobs in Indianapolis to Meet Growing Market Demand

MiraVista Diagnostics is adding several new positions across all departments to meet growing market demand for its mycology diagnostic testing services. The scientific company is actively recruiting qualified candidates for research, medical laboratory, sales and technology positions in Indianapolis. Please…
READ MORE →

Dr. Joseph Wheat is Selected as the 2015 MMSA Billy Cooper Award Winner for His Contributions in Clinical Mycology

The Medical Mycological Society of the Americas selected MiraVista Diagnostics’ President, Founder and Medical Director, Lawrence Joseph Wheat, MD, as the 2015 MMSA Billy Cooper Award winner. This prestigious award is given to individuals with continuous outstanding or meritorious contributions in the…
READ MORE →

MiraVista Diagnostics’ Blastomyces Antigen Test for Dogs Accurately and Quickly Diagnosed Blastomycosis in a German Shepherd

Clinician’s Brief published an article in December 2014 about a case of blastomycosis in a German shepherd. The case report describes a classic example of blastomycosis in a dog with a cutaneous lesion and a nodular interstitial pattern on thoracic…
READ MORE →

David Schultenover Joins MiraVista Diagnostics’ Leadership Team

Pharmaceutical and medical device industry veteran, David Schultenover,  joined MiraVista Diagnostics’ leadership team as the company’s Quality Assurance Director. In this executive management role, David Schultenover is responsible for ensuring MiraVista Diagnostics’ company-wide compliance with multiple regulatory agencies, including FDA,…
READ MORE →

Janet Raymond Joins MiraVista Diagnostics’ Leadership Team

Experienced healthcare and life science professional, Janet Raymond joined MiraVista Diagnostics’ leadership team as the company’s Sales Director. MiraVista Diagnostics Enhances Executive Team with Strategic New Hire: Janet Raymond In this executive management role, Janet Raymond is responsible for leading…
READ MORE →

MiraVista Diagnostics Moved Its Indianapolis Corporate Headquarters + Clinical Laboratory

MiraVista Diagnostics moved its corporate headquarters and clinical laboratory to a new state-of-the-art 16,000 square foot facility near the Indianapolis International Airport. This move was prompted by the company’s long-term growth and expansion. NEW ADDRESS MiraVista Diagnostics 4705 Decatur Blvd….
READ MORE →

MiraVista Diagnostics Added Beta-D Glucan Tests to its Test Menu

MiraVista Diagnostics has added beta-D glucan tests to its menu of fungal infection diagnostic antigen tests. This assay aids in the presumptive diagnosis of invasive fungal disease in at-risk patients. Contact us to learn more about beta-D glucan tests.

MiraVista Diagnostics Added Histoplasma Immunodiffusion Tests to its Fungal Test Menu

MiraVista Diagnostics has added histoplasma immunodiffusion tests to its menu of fungal infection diagnostic antibody detection tests. This assay aids in the diagnosis of fungal infections, in vitro, by detecting precipitating antibodies to fungal pathogens. Contact us to learn more…
READ MORE →

ORDER TESTS
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo